Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Global X Lithium & Battery Tech ETF
LIT
$1.59B
| $15.2M | ﹤0.01% |
392,468
-53,653
| -12% | -$2.2M |
|
2952
Trustmark
TRMK
$2.78B
| $15.2M | ﹤0.01% |
441,207
-80,187
| -15% | -$2.86M |
|
2953
First Trust NASDAQ ABA Community Bank Index Fund
QABA
$93.7M
| $15.2M | ﹤0.01% |
291,043
-96,306
| -25% | -$5.33M |
|
|
SLNO
2954
DELISTED
Soleno Therapeutics
SLNO
| $15.2M | ﹤0.01% |
212,359
+2,122
| +1% | +$103K |
|
2955
Grindr
GRND
$2.82B
| $15.2M | ﹤0.01% |
847,312
+105,943
| +14% | +$1.86M |
|
2956
Amphastar Pharmaceuticals
AMPH
$869M
| $15.1M | ﹤0.01% |
522,112
-109,962
| -17% | -$3.51M |
|
2957
First Trust Nasdaq Semiconductor ETF
FTXL
$1.33B
| $15.1M | ﹤0.01% |
199,719
-115,388
| -37% | -$9.93M |
|
|
MYD
2958
DELISTED
BlackRock MuniYield Fund
MYD
| $15.1M | ﹤0.01% |
1,426,765
+5,672
| +0.4% | +$60.5K |
|
|
EOI
2959
Eaton Vance Enhanced Equity Income Fund
EOI
$830M
| $15M | ﹤0.01% |
801,398
+41,916
| +6% | +$848K |
|
|
BCAX
2960
Bicara Therapeutics
BCAX
$1.56B
| $15M | ﹤0.01% |
1,152,131
+749,213
| +186% | +$9.95M |
|
2961
Autohome
ATHM
$2.65B
| $15M | ﹤0.01% |
541,097
+5,246
| +1% | +$149K |
|
2962
Algonquin Power & Utilities
AQN
$4.47B
| $15M | ﹤0.01% |
2,915,305
+18,880
| +0.7% | +$89.1K |
|
2963
Sunstone Hotel Investors
SHO
$1.98B
| $15M | ﹤0.01% |
1,591,183
-652,487
| -29% | -$7.08M |
|
2964
Triple Flag Precious Metals
TFPM
$6.59B
| $15M | ﹤0.01% |
781,600
+282,985
| +57% | +$4.83M |
|
2965
iShares US Pharmaceuticals ETF
IHE
$1.65B
| $15M | ﹤0.01% |
211,984
-168,637
| -44% | -$11.7M |
|
2966
Nuveen California Municipal Value Fund
NCA
$304M
| $14.9M | ﹤0.01% |
1,727,763
+103,836
| +6% | +$892K |
|
2967
Nabors Industries
NBR
$1.3B
| $14.9M | ﹤0.01% |
358,027
+141,188
| +65% | +$7.19M |
|
2968
John Hancock Multifactor Developed International ETF
JHMD
$985M
| $14.9M | ﹤0.01% |
427,110
-166,911
| -28% | -$5.71M |
|
2969
SITE Centers
SITC
$155M
| $14.9M | ﹤0.01% |
1,160,520
-740,278
| -39% | -$10.5M |
|
|
ETW
2970
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.07B
| $14.9M | ﹤0.01% |
1,804,529
-16,280
| -0.9% | -$138K |
|
2971
BlackRock Energy and Resources Trust
BGR
$426M
| $14.9M | ﹤0.01% |
1,094,727
-17,837
| -2% | -$238K |
|
|
IGD
2972
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$524M
| $14.8M | ﹤0.01% |
2,567,960
-324,141
| -11% | -$1.79M |
|
2973
National Vision
EYE
$1.77B
| $14.8M | ﹤0.01% |
1,158,027
+8,053
| +0.7% | +$95.2K |
|
2974
Regenxbio
RGNX
$703M
| $14.8M | ﹤0.01% |
2,066,895
+63,584
| +3% | +$473K |
|
|
NXRT
2975
NexPoint Residential Trust
NXRT
$631M
| $14.8M | ﹤0.01% |
373,516
-16,773
| -4% | -$663K |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.